We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > rhinitis

News List

FDA Approves Over-the-Counter Nasal Antihistamine americanpharmaceuticalreview
June 23, 2021
The U.S. FDA approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch.
BM32 vaccine developed against rhinitis europeanpharmaceuticalreview
April 30, 2019
Researchers have shown that the synthetically manufactured vaccine BM32 relieves the symptoms of rhinitis…
Divestment of rights to Alvesco, Omnaris and Zetonna to Covis Pharma worldpharmanews
November 10, 2018
AstraZeneca has entered into an agreement with Covis Pharma B.V. (Covis Pharma) to sell its rights to the medicines Alvesco (ciclesonide), used for the treatment of persistent asthma, and Omnaris and Zetonna (ciclesonide), used for the treatment of nasal